FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+6.28%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$365M
AUM Growth
+$365M
(+15%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
11.92%
Top 10 Holdings %
Top 10 Hldgs %
51.36%
Holding
54
New
2
Increased
25
Reduced
15
Closed
2
Top Buys
| 1 |
Xencor
XNCR
|
$14.1M |
| 2 |
NeoGenomics
NEO
|
$12.8M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$10.5M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$6.66M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$6.63M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$9.04M |
| 2 |
MDCO
Medicines Co
MDCO
|
$8.16M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$5.93M |
| 4 |
MacroGenics
MGNX
|
$1.48M |
| 5 |
STRM
Streamline Health Solutions
STRM
|
$652K |
Sector Composition
| 1 | Healthcare | 84.02% |
| 2 | Communication Services | 4.08% |
| 3 | Energy | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sanofi
SNY
$121B
| $289K | 0.08% | 6,720 | – | – |
|
52
Merck
MRK
$210B
| $242K | 0.07% | 4,294 | – | – |
|
53
Amgen
AMGN
$155B
| – | – | -1,105 | Closed | -$207K |
|
|
MDCO
54
DELISTED
Medicines Co
MDCO
| – | – | -220,300 | Closed | -$8.16M |
|